The Iranian study of opium and cancer (IROPICAN): rationale, design, and initial findings

M Hadji, H Rashidian, M Marzban, M Gholipour… - 2021 - trepo.tuni.fi
Background: The International Agency for Research on Cancer (IARC) recently classified
opium use as a Group 1 carcinogen. However, much remains to be studied on the relation …
被引用次数：32 相关文章

The Iranian Study of Opium and Cancer (IROPICAN): Rationale, design, and initial findings

M Hadji, H Rashidian, M Marzban… - … OF IRANIAN MEDICINE, 2021 - cris.unibo.it
Background: The International Agency for Research on Cancer (IARC) recently classified
opium use as a Group 1 carcinogen. However, much remains to be studied on the relation …

The Iranian Study of Opium and Cancer (IROPICAN): Rationale, Design, and Initial Findings

M Hadji, H Rashidian, M Marzban… - Archives of Iranian …, 2021 - pubmed.ncbi.nlm.nih.gov
Background The International Agency for Research on Cancer (IARC) recently classified
opium use as a Group 1 carcinogen. However, much remains to be studied on the relation …
[PDF] journalaim.com

[PDF][PDF] The Iranian Study of Opium and Cancer (IROPICAN): Rationale, Design, and Initial Findings

M Hadji, H Rashidian, M Marzban… - Archives of Iranian …, 2021 - journalaim.com
Background: The International Agency for Research on Cancer (IARC) recently classified
opium use as a Group 1 carcinogen. However, much remains to be studied on the relation …
[PDF] researchgate.net

[PDF][PDF] The Iranian Study of Opium and Cancer (IROPICAN): Rationale, Design, and Initial Findings

researchgate.net
Abstract Background: The International Agency for Research on Cancer (IARC) recently
classified opium use as a Group 1 carcinogen. However, much remains to be studied on the …
[PDF] bpums.ac.ir

[PDF][PDF] The Iranian Study of Opium and Cancer (IROPICAN): Rationale, Design, and Initial Findings

bpums.ac.ir
Abstract Background: The International Agency for Research on Cancer (IARC) recently
classified opium use as a Group 1 carcinogen. However, much remains to be studied on the …
[PDF] tums.ac.ir

[PDF][PDF] The Iranian Study of Opium and Cancer (IROPICAN): Rationale, Design, and Initial Findings

bdrc.tums.ac.ir
Abstract Background: The International Agency for Research on Cancer (IARC) recently
classified opium use as a Group 1 carcinogen. However, much remains to be studied on the …
[HTML] sid.ir

[HTML][HTML] The Iranian Study of Opium and Cancer (IROPICAN): Rationale, Design, and Initial Findings

M HADJI, H RASHIDIAN, M MARZBAN… - 2021 - sid.ir
Background: The International Agency for Research on Cancer (IARC) recently classified
Opium use as a Group 1 carcinogen. However, much remains to be studied on the relation …

The Iranian Study of Opium and Cancer (IROPICAN): Rationale, design, and initial findings

M Hadji, H Rashidian, M Marzban… - ARCHIVES OF …, 2021 - researchportal.tuni.fi
Background: The International Agency for Research on Cancer (IARC) recently classified
opium use as a Group 1 carcinogen. However, much remains to be studied on the relation …

The Iranian Study of Opium and Cancer (IROPICAN): Rationale, Design, and Initial Findings.

M Hadji, H Rashidian, M Marzban… - Archives of Iranian …, 2021 - search.ebscohost.com
Abstract Background: The International Agency for Research on Cancer (IARC) recently
classified opium use as a Group 1 carcinogen. However, much remains to be studied on the …